Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Jay Thakkar of Sharekhan is of the view that one can buy Glenmark Pharma with a target of Rs 902 and PNB with a target of Rs 78.50.
Manish Hathiramani, Proprietary Trader & Technical Analyst at Deen Dayal Investments recommends buying Exide Industries, Bosch and Glenmark Pharma.
R Sreesankar, Head Institutional Equities, Prabhudas Lilladher in an interview to CNBC-TV18 shared his rationale for picking Infosys, HDFC Bank, Aurobindo Pharma, Jubilant Life and Glenmark as his top picks.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Glenmark Pharma and UPL and advises selling Sun TV.
Mehraboon Irani of Nirmal Bang Securities is of the view that Glenmark Pharma and Alembic Pharmaceuticals are the best picks from the pharma space.
SP Tulsian, sptulsian.com, shares his views on Glenmark, PSU bank stocks and why he is bearish on NBFC stocks.
SP Tulsian of sptulsian.com is of the view that one may enter Glenmark Pharma.
Rajat Bose of rajatkbose.com is of the view that one may buy United Spirits and Havells India.
Prakash Gaba of prakashgaba.com feels that Reliance Industries may test Rs 1030 and TCS may move to Rs 2600.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Havells India, Hindustan Unilever and Glenmark Pharma.
Sandeep Wagle of powermywealth.com is of the view that one can buy Glenmark Pharma, Engineers India and PTC India.
Sudarshan Sukhani of s2analytics.com suggests buying Glenmark Pharma.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Maruti Suzuki on all declines.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Reliance Capital, Glenmark Pharma and United Spirits.
Gaurav Ratnaparkhi of Sharekhan advises buying IRB Infrastructure with a target of Rs 228.
Ajay Bodke of Prabhudas Lilladher has a positive view on NIIT Tech and Maruti Suzuki and has ACC and JK Lakshmi Cement as the top picks from the cement space.
The decision by Taro Pharma, Sun Pharma's Israeli subsidiary, to provide keveyis free of cost to distributors is likely to impact revenues of about USD 25 million, says Praful Bohra, VP Research at Religare.
Rajat Bose of rajatkbose.com is of the view that one can buy Hindustan Petroleum Corporation and feels that ITC may test Rs 313.
Sandeep Wagle of powermywealth.com recommends selling IRB Infra and Motherson Sumi Systems and advises buying Glenmark Pharma and United Breweries.
Rajat Bose of rajatkbose.com recommends buying Glenmark Pharma and Hindalco Industries and feels that Maruti Suzuki may test Rs 3598.
Ashwani Gujral of ashwanigujral.com recommends buying Jet Airways, Tata Chemicals and Glenmark Pharma and advises selling Bharat Forge and IRB Infra.
Gaurav Bissa of LKP Securities recommends going long in Glenmark Pharma and advises selling TVS Motor and Apollo Tyres.
Ashwani Gujral of ashwanigujral.com recommends buying Glenmark Pharma and advises selling IRB Infra and HDIL.
Prakash Gaba of prakashgaba.com is of the view that State Bank of India may test Rs 210 and advises buying Exide Industries and Glenmark Pharma.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Voltas and Dabur India and advises selling Glenmark Pharma.